Adapting Cognitive Behavioral Therapy (CBT) for Chinese Americans

NCT ID: NCT01786746

Last Updated: 2013-02-08

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 61 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2007-06-30
• Study Completion Date: 2011-03-31

Brief Summary

The goals of this study were to a) test whether cognitive behavioral therapy (CBT) is effective in treating depressed Chinese Americans, b) to develop and test the effectiveness of culturally adapt CBT, and c) to test the differential outcomes of the two treatments.

Detailed Description

It is now known that ethnic minorities are less likely to receive quality health services and evidence worse treatment outcomes when compared with other groups (IOM, 1999; USDHHS, 2001). Moreover, there continues to be a shortage of systematic investigations examining the efficacy of evidence-based treatments (EBTs) with ethnic minorities, especially among Chinese Americans. Developing interventions that are both empirically grounded and that are culturally sensitive and compatible with Chinese culture is one promising strategy that may improve treatment outcomes for this understudied group. The goal of this study is to culturally adapt a cognitive-behavioral therapy manual for use with depressed Chinese American patients. This study will be among the first to develop a culturally adapted EBT for use with this ethnic group and will involve three study phases. Phase I of the study will focus on modifying and refining a CBT intervention protocol into a manualized treatment for Chinese Americans. Phase two involves a randomized controlled trial (RCT) comparing the effects of the culturally adapted CBT treatment manual with nonadapted CBT. Phase three will involve further refinement of the treatment manual, data analysis, and report writing. Patients will be recruited from an ethnic-specific mental health center that specializes in treating Asian American clientele to participate in the study. Patients will be randomly assigned to either the adapted CBT treatment or the nonadapted CBT treatment. Moreover, feedback from patients and therapists in both conditions will be used to further refine the new treatment manual, provide valuable information about salient issues in treating depressed Chinese Americans, and will provide initial estimates of treatment parameters that will be used in preparing a larger R01 proposal to further test the adapted intervention.

Conditions

Major Depression

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Psychotherapy

Psychotherapy arm that consists of a randomization into 12 session manualized cognitive behavioral therapy or culturally adapted cognitive behavioral therapy for Chinese Americans.

Group Type: EXPERIMENTAL

cognitive behavioral therapy

Intervention Type: BEHAVIORAL

cognitive behavioral therapy. 12 sessions.

culturally adapted cognitive behavioral therapy

Intervention Type: BEHAVIORAL

culturally adapted cognitive behavioral therapy for Chinese Americans. 12 sessions.

Interventions

cognitive behavioral therapy

cognitive behavioral therapy. 12 sessions.

Intervention Type: BEHAVIORAL

culturally adapted cognitive behavioral therapy

culturally adapted cognitive behavioral therapy for Chinese Americans. 12 sessions.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• depression, Chinese American

Exclusion Criteria

• bipolar, psychotic disorder, primary substance abuse problem, severe medical conditions that induce depression

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of California, Los Angeles

OTHER

Sponsor Role: collaborator

Claremont McKenna College

OTHER

Sponsor Role: lead

Responsible Party

Wei-Chin Hwang

PI, Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Wei-Chin Hwang, PhD

Role: PRINCIPAL_INVESTIGATOR

Claremont McKenna College

Locations

Claremont McKenna College

Claremont, California, United States

Countries

United States

Other Identifiers

R34MH073545

Identifier Type: NIH

Identifier Source: org_study_id

View Link